Elder Health Care is currently trading at its upper circuit limit of Rs. 52.85, up by 2.50 points or 4.97% from its previous closing of Rs. 50.35 on the BSE.
The scrip opened at Rs. 49.00 and has touched a high and low of Rs. 52.85 and Rs. 49.00 respectively. So far 1369 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 72.00 on 25-Apr-2013 and a 52 week low of Rs. 30.75 on 19-Feb-2014.
Last one week high and low of the scrip stood at Rs. 54.50 and Rs. 49.00 respectively. The current market cap of the company is Rs. 21.14 crore.
The promoters holding in the company stood at 49.49% while Non-Institutions held 50.51% stake in the company.
Elder Health Care, after selling branded domestic formulations business to Torrent Pharmaceuticals, is reportedly planning to concentrate on the FMCG business. The company is aiming to achieve top-line of Rs 500 crore in FY 2014.
The company’s FMCG business includes various over the counter (OTC) brands, color cosmetics products along with its distribution brands including Richfeel and Stay On. Moreover, the company has been increasing its OTC portfolio over the last few years and has a total of 13 products (own and licensed) covering segments.
Elder Health Care, a part of the Elder group of companies is engaged in manufacture of a range of FMCG and Skin Care Products through research and development and also products through licensing agreements with Indian and International companies.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1678.40 |
| Dr. Reddys Lab | 1223.00 |
| Cipla | 1231.55 |
| Zydus Lifesciences | 938.05 |
| Lupin | 2307.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: